CLINICAL_TRIALS
trial_result
· 2023-07-28
Clinical Trial Update: An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) [Phase 3]
Summary
Phase 3 trial of BIIB067 (tofersen) in adults with inherited ALS completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2023-07-28